Ladoire, Sylvain, 1977-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Sylvain Ladoire
VIAF ID: 217341841 (Personal)
Permalink: http://viaf.org/viaf/217341841
Preferred Forms
-
100 1 _
‡a
Ladoire, Sylvain
‡d
1977-...
-
100 1 _
‡a
Ladoire, Sylvain,
‡d
1977-....
-
100 0 _
‡a
Sylvain Ladoire
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity |
|
| Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate |
|
| Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells |
|
| CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer |
|
| Cell-death-associated molecular patterns as determinants of cancer immunogenicity |
|
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. |
|
| La chimiothérapie néo-adjuvante du cancer du sein : évaluation de son efficacité : intérêt de la tomographie par émission de positons à partir d'une étude prospective menée au Centre G.F. Leclerc |
|
| Circulating biomarkers in metastatic castration-resistant prostate cancer. |
|
| Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? |
|
| Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis |
|
| Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists |
|
| Description du phénotype des lymphocytes T infiltrant la tumeur et de leur relation avec la survie des patientes atteintes d'un cancer ovarien de stade avancé |
|
| Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? |
|
| Etude de la réponse T CD4 anti-télomérase périphérique dans les cancers : méthodes d'analyse et intérêt pour le monitoring en immuno-oncologie |
|
| Etude préclinique des effets immunologiques d’une combinaison de chimiothérapies dans le cancer du sein triple négatif |
|
| FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial |
|
| Functional and prognostic aspects of myeloid suppressor cells and Foxp3 in cancer. |
|
| La Galectine-9 induite par les radiations ionisantes, une nouvelle cible thérapeutique,dans le cancer du sein triple négatif ? |
|
| Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer |
|
| High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study |
|
| High-pressure intrapleural chemotherapy: feasibility in the pig model |
|
| HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report |
|
| Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions |
|
| Human FOXP3 and cancer |
|
| Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma |
|
| Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy |
|
| Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens |
|
| An immunosurveillance mechanism controls cancer cell ploidy |
|
| Improving the techniques of intracavitary chemotherapy. |
|
| Isolated lung perfusion as an adjuvant treatment of colorectal cancer lung metastases: a preclinical study in a pig model |
|
| The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy |
|
| Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization |
|
| Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells |
|
| Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells |
|
| Optimisation des techniques de chimiothérapie intracavitaire |
|
| Optimisation des vaccins thérapeutiques induisant des réponses T CD8+ spécifiques d'antigènes tumoraux : étude de l'induction des lymphocytes T régulateurs après vaccination |
|
| Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer |
|
| Phenotypic characterization of the Tumor-Infiltrating Lymphocytes (TILs) and prognostic impact on advanced epithelial ovarian cancer. |
|
| Positive impact of autophagy in human breast cancer cells on local immunosurveillance |
|
| Preclinical evaluation of the immunological effects of eribulin/cisplatin : rationale combination with anti-PD-L1 immunotherapy and TGF-β targeting in TNBC. |
|
| The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer |
|
| Prognosis of local invasive relapses after in situ carcinoma of the breast : a case-control study on a population registry. |
|
| Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer |
|
| Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients |
|
| Pronostic des petites tumeurs luminales du sein sans envahissement ganglionnaire axillaire (T1N0) : revue de la littérature et apports de la classification moléculaire intrinsèque et du microenvironnement immunitaire tumoral a partir d’une étude cas-témoin |
|
| Pronostic des rechutes locales invasives après carcinome in situ du sein : étude cas-témoin sur un registre de population |
|
| Rechallenge des taxanes chez les patientes présentant un cancer du sein métastatique her2 négatif : efficacité, tolérance et survie |
|
| Rôle pronostique des infiltrats lymphocytaires T CD4 dans les cancers du sein |
|
| Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study |
|
| Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation |
|
| SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth |
|
| Study of circulating CD4 Th1 response against telomerase in cancer patients : method of analysis and interest for monitoring in immuno-oncology. |
|
| T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival |
|
| Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients |
|
| Utilité du séquençage de l’exome et des biomarqueurs d’HRD dans la prédiction de la sensibilité aux sels de platine dans une population de tumeurs mammaires métastatiques = efficacy of platinum-based chemotherapy in mestastasic breast cancer based on homologous recombination deficiency (HRD) biomarkers : utility of exome sequencing |
|
| Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents |
|
